Other enriched pathways were also linked to PRKCB, PRKCH, and PRKCQ in most cancers and to PRKCA, PRKCD, and PRKCE in some cancers including, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Natural killer cell-mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, B cell receptor signaling pathway, and Leukocyte transendothelial migration. The gene discussed is PRKCA; the disease is cancer.